Table 4.
DHEAS levels during the inpatient stay according to functional outcome 6 months after aneurysmal subarachnoid hemorrhage (dichotomized modified Rankin scale score)
| Minimum | Maximum | Mean | SD | 95 % CI | Number | |
|---|---|---|---|---|---|---|
| DHEAS day 0 | ||||||
| Favorable | <150 | 5260 | 1411 | 1161 | 1000, 1823 | 33 |
| Unfavorable | <150 | 2310 | 1052 | 678 | 766, 1338 | 24 |
| DHEAS day 1 | ||||||
| Favorable | <150 | 4460 | 1135 | 1035 | 768, 1502 | 33 |
| Unfavorable | <150 | 2740 | 820 | 609 | 563, 1077 | 24 |
| DHEAS day 4 | ||||||
| Favorable | <150 | 2840 | 699 | 700 | 451, 948 | 33 |
| Unfavorable | <150 | 1700 | 515 | 497 | 283, 748 | 20 |
| DHEAS day 7 | ||||||
| Favorable | <150 | 3780 | 770 | 838 | 467, 1072 | 32 |
| Unfavorable | <150 | 1110 | 339 | 324 | 187, 491 | 20 |
| DHEAS day 10 | ||||||
| Favorable | 155 | 5770 | 982 | 1251 | 523, 1441 | 31 |
| Unfavorable | <150 | 776 | 255 | 249 | 127, 383 | 17 |
| DHEAS day 14 | ||||||
| Favorable | <150 | 2560 | 669 | 604 | 435, 903 | 28 |
| Unfavorable | <150 | 1090 | 359 | 342 | 153, 566 | 13 |
Dehydroepiandrosterone-sulfate (DHEAS) levels (ng/ml) during acute stage of disease according to dichotomized (Favorable vs Unfavorable) outcome 6 months after aneurysmal subarachnoid hemorrhage. Number number of cases analyzed